Darren J. Guttenberg
Partner
Orange County
darren.guttenberg@lw.com
+1.714.755.8050
PRACTICES
- Capital Markets
- Mergers & Acquisitions
- Public Company Representation
INDUSTRIES
- Financial Institutions
- Healthcare & Life Sciences
- REITs
- Retail & Consumer Products
- Technology
EDUCATION
- JD, University of Southern California Law School, 2013
- BA, University of California, Los Angeles, 2007
LANGUAGES SPOKEN
PROFILE
Darren Guttenberg advises public and private companies on a wide array of corporate matters, including mergers and acquisitions, capital markets transactions, securities laws, and corporate governance.
Darren helps companies navigate complex transactions, achieve regulatory compliance, and manage business-critical shareholder issues, including:
- Mergers and acquisitions
- Capital markets transactions
- Joint ventures
- Shareholder activism
- General corporate representation
As a versatile lawyer, Darren regularly advises clients across a range of industries. His ability to grasp the big picture allows him to help clients identify effective business solutions even under volatile market conditions and high-pressure situations.
He draws on his wide range of experiences to quickly learn a client’s business and develop trusted relationships.
EXPERIENCE
Darren's representative transactions include advising:
Mergers & Acquisitions
- INDUS Realty Trust in its US$868 million acquisition by Centerbridge and GIC
- Publicly traded homebuilding company in its US$520 million acquisition of a private homebuilder
- Publicly traded REIT in its US$868 million sale to a private equity firm
- Publicly traded homebuilder in its acquisition of several private homebuilders
- Publicly traded biopharmaceutical company in its US$70.5 billion sale to a global biopharmaceutical company
- Publicly traded consumer electronics company in its US$200 million sale to a private equity firm
- Private business services company in its US$2.0 billion acquisition of a competitive business services company
- Publicly traded REIT in its US$16.2 billion sale to another REIT
- Private medical device company in its sale to another medical device company
- Publicly traded biopharmaceutical company in its defense of a hostile takeover attempt
- Publicly traded medical device company in its US$1.7 billion sale to a global healthcare company
Capital Markets
- Homebuilding company in its US$350 million private offering of senior notes
- Homebuilding company in its public offering of tangible equity units
- The underwriters in an IPO of common stock of a medical device company
- REIT in over US$5.6 billion in public offerings of debt and common stock
- The underwriters in an IPO of a biopharmaceutical company in its US IPO of American depositary shares
- Homebuilding company in its US$50 million public offering of common stock
- Biopharmaceutical company in its US$230 million public offering of convertible notes
- Homebuilding company in its US$250 million private offering of senior notes